National Account Director Payer Accounts

Job Purpose

The National Account Director is the dedicated external-facing lead for one of the big three national PBM/GPO accounts (e.g. CVS Caremark/Zinc Express Scripts/Ascent Optum Rx/Emisar). Drawing on established relationships with decision makers at that account this individual drives timely and favorable access for sonelokimab. The role executes the account plan leads Pre-approval Information Exchange (PIE) and formulary discussions supports contract negotiations and pull-through and brings account insights back into the access pricing and contracting strategy.

Your profile

Major Accountabilities

• Pre-Launch (FDA 24 to 0 months)
  • Account mapping: Map the decision-making structure influencers processes and timelines of the assigned account including PBM GPO P&T and clinical committees and key affiliated health plans
  • Account plan: Develop and execute the account plan in line with the overall payer engagement and contracting strategy
  • Relationship building: Use and deepen existing senior relationships across clinical trade and contracting functions at the assigned account
  • PIE engagement: Lead compliant PIE discussions with the assigned account
  • Account insights: Feed account-specific insights into the access strategy payer value proposition PIE decks AMCP dossier and contracting strategy
  • Contract preparation: Work with Pricing & Contracting to identify the accounts likely contract requirements key terms and deal scenario
• Launch & Post-Approval (FDA approval to 612 months post)
  • Formulary review: Lead formulary review meetings and clinical presentations with the assigned account
  • Contract negotiation support: Support rebate negotiations with Pricing & Contracting within approved guardrails and support contract execution
  • Pull-through: Drive pull-through of coverage wins with the account and its downstream health plans together with FRMs and sales
  • Coverage tracking: Track policy development formulary tiers and utilization management criteria at the account and communicate coverage updates to internal teams
  • Issue resolution: Escalate and resolve access barriers such as restrictive PA criteria step edits and specialty pharmacy requirements with the account
  • Account reporting: Report on account status risks and opportunities to the Payer Account Team Lead and cross-functional partners

Job Requirements

Education:

• Bachelors degree required
• Advanced degree (MSc MBA PhD PharmD or MD) strongly preferred

Experience:

• 8 years of U.S. market access or payer account experience including national account management
• Established senior relationships at one of the big three PBM/GPO organizations (CVS Caremark/Zinc Express Scripts/Ascent or Optum Rx/Emisar)

Skills/knowledge/behavioural competencies:

• Deep knowledge of the assigned accounts decision processes P&T and formulary cycles and contracting practices
• Experience supporting rebate negotiations and contract pull-through
• Specialty or immunology launch experience preferred
• Familiarity with PIE AMCP dossier standards and compliant payer interactions
• Strong external presentation negotiation and relationship skills
• Willingness to travel frequently to account sites and internal meetings

Why us

An exciting job opportunity awaits you!
MoonLake is a dynamic and innovative company pushing the boundaries of possibility and we are looking for passionate individuals to join our stellar team.

What we offer:
Learning Environment: An opportunity to learn and grow alongside experienced professionals in a supportive and innovative biotech environment.
Impactful Work: Contribute to ground-breaking projects that have the potential to transform global healthcare.
Flexibility and Balance: Enjoy a healthy work-life balance while making meaningful contributions to our team.
Career Growth: A clear path for career progression with the chance to take on more responsibilities as you develop your skills.

About us

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab a novel investigational Nanobody for the treatment of the inflammatory disease to revolutionize outcomes for patients.

We continue to make significant progress in our Global Clinical Development Programs. The companys focus is on inflammatory diseases with a major unmet need including hidradenitis suppurativa and psoriatic arthritis conditions affecting millions of people worldwide with a large need for improved treatment options. MoonLake was founded in 2021 and is headquarted in Zug with hubs in Cambridge & Porto.

Further information is available at

Required Experience:

Director